K.E. Livingston
Pharmacologic evidence for a putative conserved allosteric site on opioid receptors
Livingston, K.E.; Stanczyk, M.A.; Burford, N.T.; Alt, A.; Canals, M.; Traynor, J.R.
Authors
M.A. Stanczyk
N.T. Burford
A. Alt
MERITXELL CANALS M.CANALS@NOTTINGHAM.AC.UK
Professor of Cellular Pharmacology
J.R. Traynor
Abstract
Allosteric modulators of G protein-coupled receptors, including opioid receptors, have been proposed as possible therapeutic agents with enhanced selectivity. BMS-986122 is a positive allosteric modulator (PAM) of the μ-opioid receptor (μ-OR). BMS-986187 is a structurally distinct PAM for the δ-opioid receptor (δ-OR) that has been reported to exhibit 100-fold selectivity in promoting δ-OR over μ-OR agonism. We used ligand binding and second-messenger assays to show that BMS-986187 is an effective PAM at the μ-OR and at the κ-opioid receptor (κ-OR), but it is ineffective at the nociceptin receptor. The affinity of BMS-986187 for δ-ORs and κ-ORs is approximately 20- to 30-fold higher than for μ-ORs, determined using an allosteric ternary complex model. Moreover, we provide evidence, using a silent allosteric modulator as an allosteric antagonist, that BMS-986187 and BMS-986122 bind to a similar region on all three traditional opioid receptor types (μ-OR, δ-OR, and κ-OR). In contrast to the dogma surrounding allosteric modulators, the results indicate a possible conserved allosteric binding site across the opioid receptor family that can accommodate structurally diverse molecules. These findings have implications for the development of selective allosteric modulators. Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.
Citation
Livingston, K., Stanczyk, M., Burford, N., Alt, A., Canals, M., & Traynor, J. (2018). Pharmacologic evidence for a putative conserved allosteric site on opioid receptors. Molecular Pharmacology, 93(2), 157-167. https://doi.org/10.1124/mol.117.109561
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 27, 2017 |
Online Publication Date | Jan 12, 2018 |
Publication Date | Feb 1, 2018 |
Deposit Date | Jan 13, 2020 |
Print ISSN | 0026-895X |
Publisher | American Society for Pharmacology and Experimental Therapeutics |
Peer Reviewed | Peer Reviewed |
Volume | 93 |
Issue | 2 |
Pages | 157-167 |
DOI | https://doi.org/10.1124/mol.117.109561 |
Keywords | bms 986122; bms 986187; delta opiate receptor; kappa opiate receptor; mu opiate receptor; nociceptin receptor; opiate agonist; opiate antagonist; opiate receptor; unclassified drug; allosteric site; animal cell; Article; binding affinity; binding site; co |
Public URL | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041169717&doi=10.1124%2fmol.117.109561&partnerID=40&md5=ba991a91eb1bcfce83371990e736efde |
Publisher URL | http://molpharm.aspetjournals.org/content/93/2/157/tab-article-info |
You might also like
Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor
(2014)
Journal Article
The role of kinetic context in apparent biased agonism at GPCRs
(2016)
Journal Article
Fluorescently Labeled Morphine Derivatives for Bioimaging Studies
(2018)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search